Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II study.
暂无分享，去创建一个
A. Addeo | B. Calgua | M. Joerger | S. Haefliger | P. Jermann | S. Rothschild | I. Alborelli | N. Mach | M. Mark | M. Schneider | M. Frueh | L. Mauti | Eugenio Fernandez | C. Waibel | S. Savic-Prince | Lisa Holer